…In patients with acute coronary syndromes (ACS), the early post event period is particularly vulnerable, and delayed intensification of lipid lowering therapy may leave patients…

…a patient who has little or no reliable intrinsic rhythm may develop prolonged pauses. Pacing dependent patients therefore require protection against inhibition during the period…

…undergo urgent coronary angiography with the intent of performing PCI. The COACT, PEARL and TOMAHAWK trials studied patients with ROSC who did not display ST…

…Invitations are sent up to and including the age of 70, and the last sample is in practice taken some time between the ages of…

…hemodynamically and respiratory) and fully conscious patients who experienced a brief cardiac arrest. Post resuscitation care is an integral component of the chain of survival…

…a distinct disease. It identifies patients whose blood pressure remains uncontrolled despite intensive antihypertensive treatment and who therefore require assessment for pseudo resistance, secondary hypertension…

…73 m². Recalculate in patients who are markedly larger or smaller than average. Higher doses may be required in the critically ill patient. Intravenous antibiotics…

…serves as a tool to identify patients who may require more careful monitoring and management of modifiable risk factors. The HAS BLED score has demonstrated…

…long term prognosis are worse than in patients who remain in sinus rhythm. Several mechanisms may account for apparent ischaemic electrocardiographic changes during rapid AF…

…L). Non statin treatment for patients who are statin intolerant. Possible concurrent initiation of ezetimibe with maximally tolerated statin therapy during ACS hospitalization. European recommendations…

…patients who do not achieve satisfactory effects using first line therapies. Digoxin is also used frequently in the emergency setting to control ventricular rate during…

…which enables the clinician to examine intracardiac ECGs at any time. However, most clinicians who encounter patients with pacemakers only have access to conventional surface…

…necessary to perform an exercise stress test, during which it is fundamentally important that the patient performs maximally. Only two variables are needed to determine…

…in the size of the thrombus. This means that a patient who experienced chest pain at home may be asymptomatic during the assessment in the…

…rise during treatment with ticagrelor. The mechanism is unclear. Kidney function should be monitored according to clinical practice. Special attention should be given to patients…

…This approach fails to identify a substantial subset of patients with acute coronary occlusion (ACO) who do not meet the established ECG criteria for STEMI…

…All patients with severe acute heart failure who receive levosimendan should be monitored invasively (e.g. arterial line, PiCCO, central venous catheter). The hemodynamic effects…

…The incidence is 10–34% among patients with premature ventricular contractions and/or nonsustained ventricular tachycardia who are referred for electrophysiological evaluation (Hasdemir et al…

…for at least 72 hours for as long as the unconsciousness persists. An awake patient who obeys commands after ROSC needs no targeted temperature management…

…surgery Relevant patient category 27.5 mm/m 2 Turner syndrome 40 mm • Patients with mutations in TGFBR1, TGFBR2 or Loes Dietz syndrome, who have…

…includes stable patients who are not low risk but have either RV dysfunction or elevated biomarkers, or neither of these abnormalities in the presence of…

…orthostatic hypotension Multimorbidity Polypharmacy and overall therapeutic burden Life expectancy Patient priorities and preferences Patients who are fit and independent generally benefit from guideline directed…

…patients with low blood pressure secondary to a low cardiac output. Its primary clinical utility in contemporary practice is late line therapy for patients who…

…90% deteriorate during hospitalization. Patients who develop shock often have severe multivessel coronary disease and progressive, “piece meal” necrosis extending beyond the original infarct zone…

…Most patients who report intolerance can ultimately take some form of statin therapy after systematic reassessment and rechallenge. The principal manifestation is statin associated muscle…

…The specificity of absent pupillary reflex for predicting a poor neurological outcome was 68.8%. This implies that approximately one third of the patients who…

…instability. Fewer than 1% of patients with ST elevation myocardial infarction (STEMI) who reach the catheterization laboratory are found to have complete LMCA occlusion, likely…

…overt ischemic signs during stress testing (Bourque et al.). Thus, patients who undergo exercise stress testing must achieve at least 85% of the age adjusted…

…or in those who are otherwise haemodynamically unstable. The benefit of its administration in these patients should be carefully balanced against the potential risks resulting…

…with elevated BP who do not already have a condition conferring sufficiently high cardiovascular risk. They should not be applied as the principal risk tool…

…affects the appropriate scope and duration of family surveillance. For example, heterozygous carriers in a clearly recessive cardiomyopathy may not require the same follow up…

…which seeks to prevent the development of cardiovascular risk factors themselves, and from secondary prevention, which addresses patients with established disease to reduce recurrent events…

…the risk of peripheral artery disease, myocardial infarction, premature death, recurrent infarction and limb threatening complications. Among patients with established peripheral artery disease, those who…

…and virtually all these patients will develop myocardial infarction, which is classified as STEMI (ST Elevation Myocardial Infarction) . NSTE ACS is the acronym for Non…

…The designation "Heart Failure with improved Ejection Fraction" (HFimpEF) is now applied to patients with a baseline LVEF ≤40% who have experienced a ≥10 point…

…treatment inertia, in which patients remain on an inadequate single drug regimen for prolonged periods. The evidence supports improved blood pressure control and adherence, although…

…dL) may be considered in the circumstances specified by the guideline. PCSK9 inhibitors are also relevant in statin intolerant patients who remain above goal despite…

…status and walking capacity, because these may reveal “masked” PAD in patients who do not exert themselves sufficiently to provoke symptoms. Intermittent claudication Intermittent claudication…

…can refine the decision to test and may identify patients who require preventive therapy even when functional testing is normal. Probability categories The source material…

…Patients who have been prescribed sublingual nitroglycerin should be instructed in its appropriate use, although specific dosing instructions are not provided in the source material…

…The absence of obstructive disease generally indicates a more favourable course than VA accompanied by severe fixed lesions. Nevertheless, patients who develop serious arrhythmias during…

…time during the disease course. Some patients may experience an acute coronary syndrome as the first manifestation of their coronary artery disease. Moreover, patients who…

…time during the disease course. Some patients may experience an acute coronary syndrome as the first manifestation of their coronary artery disease. Moreover, patients who…

…transmissible agents according to the current transmission risk assessment. In DCD: patients in whom death must be confirmed after a 20 minute no touch period…

…Follow the local definition where one exists, but a neutropenic patient who is clinically unwell must be managed as an emergency even at a lower…

…follow up is usually sufficient. Shared decision making The calculator provides a quantitative estimate of SCD risk, which facilitates informed discussions between clinicians and patients…

…Over a median follow up of 40.6 months, the time averaged LDL C difference between bempedoic acid and placebo was 0.57 mmol/L…

…as prognostic markers during the disease course. In summary, the risk of severe disease and death is several times higher in patients with cardiovascular diseas

…a 50% reduction from baseline. For a patient who experiences a recurrent atherothrombotic event while receiving maximally tolerated statin therapy, an LDL C goal below…

…populations, such as asymptomatic patients with pre excitation who have high risk occupations or participate in competitive athletics. In the context of Brugada syndrome (BrS)…

…and gardening may provide useful activity for individuals who are reluctant to undertake formal exercise. Increasing movement during daily living is a practical initial strategy…

…Some patients have frequent symptomatic episodes, whereas others have brief or asymptomatic episodes that are not detected during routine clinical assessment. The clinical burden of…

…of the cause. A person who is not breathing will therefore develop a cardiac arrest. During the first minute after a cardiac arrest, the person…

…patient who exhibits an ecotdense mass entrenched in the endocardium with impaired mobility (for example, after myocardial infarction), most likely has a parietal thrombus. The…

…Patients with acute myocardial infarction may present with typical ischemic chest pain, or with dyspnea, nausea, unexplained weakness, or a combination of these symptoms. The…

…In such scenarios, it is very common to provide the patient with a permanent pacemaker to continue optimal medical treatment. Sick sinus syndrome (sinus node…

…should be organized by certified instructors who design their courses in accordance with official guidelines (ERC, AHA, ACC). The chain of survival EARLY RECOGNITION OF…

…In selected patients, P2Y12 inhibitor monotherapy may be used as a de escalation strategy after a period of DAPT. The therapeutic objective is to reduce…

…studied 132 patients who unexpectedly experienced sudden cardiac arrest while being monitored with Holter ECG (the indications were palpitations, chest pain, syncope, etc.). The results…

…sampling and follow up — relative, but in practice decisive. INR target ranges Indication Target range Comment : : : Atrial fibrillation 2.0–3.0 The time in…